OOIR: Observatory of International Research

Papers

(The TQCC of Frontiers in Oncology is 7. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)

Article	Citations
The role of BCL-2 family proteins in regulating apoptosis and cancer therapy	235
PI3K/Akt/mTOR Pathway and Its Role in Cancer Therapeutics: Are We Making Headway?	197
Multidrug Resistance in Cancer: Understanding Molecular Mechanisms, Immunoprevention and Therapeutic Approaches	192
Long Non-Coding RNAs: The Regulatory Mechanisms, Research Strategies, and Future Directions in Cancers	177
Tumor-Induced Inflammatory Cytokines and the Emerging Diagnostic Devices for Cancer Detection and Prognosis	163
microRNAs Biogenesis, Functions and Role in Tumor Angiogenesis	146
Mechanisms for Modulating Anoikis Resistance in Cancer and the Relevance of Metabolic Reprogramming	144
The Crosstalk Between Tumor Cells and the Immune Microenvironment in Breast Cancer: Implications for Immunotherapy	139
Boron Neutron Capture Therapy: A Review of Clinical Applications	138
Identification and Verification of Immune-Related Gene Prognostic Signature Based on ssGSEA for Osteosarcoma	137
Mutant p53 in Cancer Progression and Targeted Therapies	133
The Crosstalk Between Tumor-Associated Macrophages (TAMs) and Tumor Cells and the Corresponding Targeted Therapy	133
Melanoma, Melanin, and Melanogenesis: The Yin and Yang Relationship	132
Artificial Convolutional Neural Network in Object Detection and Semantic Segmentation for Medical Imaging Analysis	122
Obesity, Type 2 Diabetes, and Cancer Risk	108
IL-6/STAT3 Is a Promising Therapeutic Target for Hepatocellular Carcinoma	107
The Role of the Transcription Factor EGR1 in Cancer	107
The Current Treatment Paradigm for Pancreatic Ductal Adenocarcinoma and Barriers to Therapeutic Efficacy	107
IL-6/JAK/STAT3 Signaling in Breast Cancer Metastasis: Biology and Treatment	106
Therapeutic Implications of Caffeic Acid in Cancer and Neurological Diseases	105
Sexual Dimorphism in Colon Cancer	105
A Review on Anti-Tumor Mechanisms of Coumarins	105
FLT3 Mutations in Acute Myeloid Leukemia: Key Concepts and Emerging Controversies	105
The role of IL-6/JAK2/STAT3 signaling pathway in cancers	105
Tumor Suppressor miRNA in Cancer Cells and the Tumor Microenvironment: Mechanism of Deregulation and Clinical Implications	104

Immune Checkpoint Inhibitors in Triple Negative Breast Cancer Treatment: Promising Future Prospects	104
Has COVID-19 Affected Cancer Screening Programs? A Systematic Review	103
Role of GPX4-Mediated Ferroptosis in the Sensitivity of Triple Negative Breast Cancer Cells to Gefitinib	102
CAFs Interacting With TAMs in Tumor Microenvironment to Enhance Tumorigenesis and Immune Evasion	98
IGF2BP2 Promotes Liver Cancer Growth Through an m6A-FEN1-Dependent Mechanism	97
The Role of Cystine/Glutamate Antiporter SLC7A11/xCT in the Pathophysiology of Cancer	96
Clinical and Biological Significances of a Ferroptosis-Related Gene Signature in Glioma	96
Global Research Trends on Prostate Diseases and Erectile Dysfunction: A Bibliometric and Visualized Study	95
FDA-Approved and Emerging Next Generation Predictive Biomarkers for Immune Checkpoint Inhibitors in Cancer Patients	91
Osteosarcoma and Metastasis	89
Immunotherapy in Treating EGFR-Mutant Lung Cancer: Current Challenges and New Strategies	88
Predictive Biomarkers for Checkpoint Inhibitor-Based Immunotherapy in Hepatocellular Carcinoma: Where Do We Stand?	87
Lactate Modulates Cellular Metabolism Through Histone Lactylation-Mediated Gene Expression in Non-Small Cell Lung Cancer	87
MYCN Function in Neuroblastoma Development	87
Etiology of Hepatocellular Carcinoma: Special Focus on Fatty Liver Disease	87
Current Triple-Negative Breast Cancer Subtypes: Dissecting the Most Aggressive Form of Breast Cancer	86
Tumor Associated Macrophages: Origin, Recruitment, Phenotypic Diversity, and Targeting	86
Cancer in Africa: The Untold Story	85
MiRNA and LncRNA as Potential Biomarkers in Triple-Negative Breast Cancer: A Review	85
Sintilimab: A Promising Anti-Tumor PD-1 Antibody	85
Immune Checkpoint Inhibitors in the Treatment of HCC	85
Knowledge Domain and Emerging Trends in Ferroptosis Research: A Bibliometric and Knowledge-Map Analysis	85
Clinical and Pharmacologic Differences of CDK4/6 Inhibitors in Breast Cancer	83
Obesity and Breast Cancer: A Paradoxical and Controversial Relationship Influenced by Menopausal Status	83
CCL2: An Important Mediator Between Tumor Cells and Host Cells in Tumor Microenvironment	83
Biomarkers of Checkpoint Inhibitor Induced Immune-Related Adverse Events—A Comprehensive Review	82
FLASH Radiotherapy: History and Future	82
FOXM1 and Cancer: Faulty Cellular Signaling Derails Homeostasis	82
Fibroblast Activation Protein-α as a Target in the Bench-to-Bedside Diagnosis and Treatment of Tumors: A Narrative Review	81
PIK3CA Mutations as a Molecular Target for Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer	81
CDK9: A Comprehensive Review of Its Biology, and Its Role as a Potential Target for Anti-Cancer Agents	81
5-Fluorouracil: A Narrative Review on the Role of Regulatory Mechanisms in Driving Resistance to This Chemotherapeutic Agent	80
Clinical Perspective of FDA Approved Drugs With P-Glycoprotein Inhibition Activities for Potential Cancer Therapeutics	80
A Review of Newly Diagnosed Glioblastoma	80
EBV-Positive Gastric Cancer: Current Knowledge and Future Perspectives	80
The Metabolic Mechanisms of Breast Cancer Metastasis	79
Strategies for Targeting Gene Therapy in Cancer Cells With Tumor-Specific Promoters	77
The Mevalonate Pathway, a Metabolic Target in Cancer Therapy	76
Genome-Wide Sex and Gender Differences in Cancer	76
Circulating Tumor DNA and Minimal Residual Disease (MRD) in Solid Tumors: Current Horizons and Future Perspectives	75
The Mechanism of Warburg Effect-Induced Chemoresistance in Cancer	75
Immunosuppression in Glioblastoma: Current Understanding and Therapeutic Implications	75
RETRACTED: CAR-NK Cell: A New Paradigm in Tumor Immunotherapy	74
Patient-Derived Organoids in Precision Medicine: Drug Screening, Organoid-on-a-Chip and Living Organoid Biobank	74
Hepatic Arterial Infusion Chemotherapy Combined With PD-1 Inhibitors Plus Lenvatinib Versus PD-1 Inhibitors Plus Lenvatinib for Advanced Hepatocellular Carcinoma	73
The Role of Gut Barrier Dysfunction and Microbiome Dysbiosis in Colorectal Cancer Development	72
YTHDF1 Is a Potential Pan-Cancer Biomarker for Prognosis and Immunotherapy	72
Probiotics in Cancer	70
The Role of Iron in Cancer Progression	70
PPAR-α Modulators as Current and Potential Cancer Treatments	69

Patient-Derived Cancer Organoids as Predictors of Treatment Response	69
Analysis of N6-Methyladenosine Methyltransferase Reveals METTL14 and ZC3H13 as Tumor Suppressor Genes in Breast Cancer	69
An Inflammatory Response-Related Gene Signature Can Impact the Immune Status and Predict the Prognosis of Hepatocellular Carcinoma	69
Extracellular Matrix Stiffness: New Areas Affecting Cell Metabolism	69
Targeting Pyrimidine Metabolism in the Era of Precision Cancer Medicine	69
LncRNA-Encoded Peptide: Functions and Predicting Methods	69
Immunotherapy in Acute Myeloid Leukemia: Where We Stand	68
The Era of Radiogenomics in Precision Medicine: An Emerging Approach to Support Diagnosis, Treatment Decisions, and Prognostication in Oncology	67
Cancer-Associated Fibroblasts and Tumor-Associated Macrophages in Cancer and Cancer Immunotherapy	67
Targeting Hypoxia: Hypoxia-Activated Prodrugs in Cancer Therapy	67
Single-Cell Transcriptomics Reveals the Complexity of the Tumor Microenvironment of Treatment-Naive Osteosarcoma	67
From Immunogenic Cell Death to Immunogenic Modulation: Select Chemotherapy Regimens Induce a Spectrum of Immune-Enhancing Activities in the Tumor Microenvironment	67
Radiation Resistance: A Matter of Transcription Factors	65
Induction of Pyroptosis: A Promising Strategy for Cancer Treatment	65
The Role of CD276 in Cancers	65
Association of Immune Related Adverse Events With Efficacy of Immune Checkpoint Inhibitors and Overall Survival in Cancers: A Systemic Review and Meta-analysis	64
Immunotherapy for Head and Neck Cancer: A Paradigm Shift From Induction Chemotherapy to Neoadjuvant Immunotherapy	64
The Resistance Mechanisms and Treatment Strategies for ALK-Rearranged Non-Small Cell Lung Cancer	64
pH-Responsive Polymer Nanomaterials for Tumor Therapy	64
Cholesterol Metabolic Reprogramming in Cancer and Its Pharmacological Modulation as Therapeutic Strategy	64
Integration of scRNA-Seq and Bulk RNA-Seq to Analyse the Heterogeneity of Ovarian Cancer Immune Cells and Establish a Molecular Risk Model	64
The PDAC Extracellular Matrix: A Review of the ECM Protein Composition, Tumor Cell Interaction, and Therapeutic Strategies	64
m5C RNA Methylation Regulators Predict Prognosis and Regulate the Immune Microenvironment in Lung Squamous Cell Carcinoma	64
Making a Cold Tumor Hot: The Role of Vaccines in the Treatment of Glioblastoma	63
Acetyl-CoA Carboxylases and Diseases	63
Concurrent Genetic Alterations and Other Biomarkers Predict Treatment Efficacy of EGFR-TKIs in EGFR-Mutant Non-Small Cell Lung Cancer: A Review	63
68Ga-FAPI-04 Versus 18F-FDG PET/CT in the Detection of Hepatocellular Carcinoma	63
Understanding Sources of Variation to Improve the Reproducibility of Radiomics	63
Cyclooxygenase-2 Inhibitor: A Potential Combination Strategy With Immunotherapy in Cancer	62
Nano-Drug Delivery Systems Entrapping Natural Bioactive Compounds for Cancer: Recent Progress and Future Challenges	62
Glioblastoma Organoids: Pre-Clinical Applications and Challenges in the Context of Immunotherapy	61
Pyroptosis-Related Gene Signatures Can Robustly Diagnose Skin Cutaneous Melanoma and Predict the Prognosis	60
Decoding Melanoma Development and Progression: Identification of Therapeutic Vulnerabilities	60
Dysbiosis of Oral Microbiota During Oral Squamous Cell Carcinoma Development	60
Photobiomodulation therapy in management of cancer therapy-induced side effects: WALT position paper 2022	60
A Deep Multi-Task Learning Framework for Brain Tumor Segmentation	59
Evolution of Experimental Models in the Study of Glioblastoma: Toward Finding Efficient Treatments	59
Platelet-Cancer Interplay: Molecular Mechanisms and New Therapeutic Avenues	59
Single-Cell RNA Sequencing in Multiple Pathologic Types of Renal Cell Carcinoma Revealed Novel Potential Tumor-Specific Markers	59
GLI1: A Therapeutic Target for Cancer	59
MR-Guided Radiotherapy for Prostate Cancer	59
Cancer chemotherapy: insights into cellular and tumor microenvironmental mechanisms of action	58
Escape From Treatment; the Different Faces of Leukemic Stem Cells and Therapy Resistance in Acute Myeloid Leukemia	58
Establishment and Initial Experience of Clinical FLASH Radiotherapy in Canine Cancer Patients	58
Progress and Challenges of Predictive Biomarkers for Immune Checkpoint Blockade	58
Development of EGFR TKIs and Options to Manage Resistance of Third-Generation EGFR TKI Osimertinib: Conventional Ways and Immune Checkpoint Inhibitors	57
Artificial Intelligence in Cervical Cancer Screening and Diagnosis	57
Urinary Biomarkers and Their Potential for the Non-Invasive Detection of Endometrial Cancer	57
Beyond Tumor Mutation Burden: Tumor Neoantigen Burden as a Biomarker for Immunotherapy and Other Types of Therapy	56
Tumor acidity: From hallmark of cancer to target of treatment	56
Trends in Intracranial Glioma Incidence and Mortality in the United States, 1975-2018	56
An Original Ferroptosis-Related Gene Signature Effectively Predicts the Prognosis and Clinical Status for Colorectal Cancer Patients	56
Deep Learning With Radiomics for Disease Diagnosis and Treatment: Challenges and Potential	56
Identification of a Ferroptosis-Related LncRNA Signature as a Novel Prognosis Model for Lung Adenocarcinoma	56
Clinical Applications and Anticancer Effects of Antimicrobial Peptides: From Bench to Bedside	55
Tumor-Associated Macrophages: A Potential Target for Cancer Therapy	55
Human Papillomavirus-Negative Cervical Cancer: A Comprehensive Review	55
The Role of EBV-Encoded LMP1 in the NPC Tumor Microenvironment: From Function to Therapy	54
The Role of Liquid Biopsy in Early Diagnosis of Lung Cancer	54
The Lipid Metabolic Landscape of Cancers and New Therapeutic Perspectives	54
Regulatory T-Cells as an Emerging Barrier to Immune Checkpoint Inhibition in Lung Cancer	54
Response Efficacy of PD-1 and PD-L1 Inhibitors in Clinical Trials: A Systematic Review and Meta-Analysis	54
Lobular Breast Cancer: A Review	54
Targeting Tim-3 in Cancer With Resistance to PD-1/PD-L1 Blockade	54
The Implications of PDK1–4 on Tumor Energy Metabolism, Aggressiveness and Therapy Resistance	54
Macrophages and Extracellular Matrix in Breast Cancer: Partners in Crime or Protective Allies?	53
In Real Life, Low-Level HER2 Expression May Be Associated With Better Outcome in HER2-Negative Breast Cancer: A Study of the National Cancer Center, China	53
CXCR4 and CXCR7 Signaling Pathways: A Focus on the Cross-Talk Between Cancer Cells and Tumor Microenvironment	53
Advances in the Prevention and Treatment of Obesity-Driven Effects in Breast Cancers	53
The Dual Role of Macropinocytosis in Cancers: Promoting Growth and Inducing Methuosis to Participate in Anticancer Therapies as Targets	53
Perioperative Outcome of Robotic Approach Versus Manual Videothoracoscopic Major Resection in Patients Affected by Early Lung Cancer: Results of a Randomized Multicentric Study (ROMAN Study)	52
Venetoclax-Based Combinations in Acute Myeloid Leukemia: Current Evidence and Future Directions	52
Multiphasic Prehabilitation Across the Cancer Continuum: A Narrative Review and Conceptual Framework	52
Present and Future Perspective on PLK1 Inhibition in Cancer Treatment	52
Small Molecules Targeting HATs, HDACs, and BRDs in Cancer Therapy	52
Emerging Role of E2F Family in Cancer Stem Cells	52
The Role of Non-Coding RNAs in Controlling Cell Cycle Related Proteins in Cancer Cells	52
Heparan Sulfate Biosynthesis and Sulfation Profiles as Modulators of Cancer Signalling and Progression	52
Advancement of Scaffold-Based 3D Cellular Models in Cancer Tissue Engineering: An Update	51
Anticancer Properties of Curcumin Against Colorectal Cancer: A Review	51

Inhibition of LDH-A by Oxamate Enhances the Efficacy of Anti-PD-1 Treatment in an NSCLC Humanized Mouse Model	51
Triggered Drug Release From Liposomes: Exploiting the Outer and Inner Tumor Environment	51
From CAR-T Cells to CAR-NK Cells: A Developing Immunotherapy Method for Hematological Malignancies	50
Multimodal Deep Learning for Prognosis Prediction in Renal Cancer	50
The Molecular Basis and Therapeutic Aspects of Cisplatin Resistance in Oral Squamous Cell Carcinoma	50
The Global Research of Artificial Intelligence on Prostate Cancer: A 22-Year Bibliometric Analysis	50
Fecal Microbiota and Gut Microbe-Derived Extracellular Vesicles in Colorectal Cancer	50
Emerging Role of PARP Inhibitors in Metastatic Triple Negative Breast Cancer. Current Scenario and Future Perspectives	50
Humanized Mice as a Valuable Pre-Clinical Model for Cancer Immunotherapy Research	50
The Efficacy of TACE Combined With Lenvatinib Plus Sintilimab in Unresectable Hepatocellular Carcinoma: A Multicenter Retrospective Study	50
MiR-27a-3p Promotes Non-Small Cell Lung Cancer Through SLC7A11-Mediated-Ferroptosis	50
Characterization of the Prognostic m6A-Related lncRNA Signature in Gastric Cancer	50
Peritoneal Metastases From Colorectal Cancer: Defining and Addressing the Challenges	49
Targeting MYCN in Pediatric and Adult Cancers	49
Targeting Glioblastoma Stem Cells: A Review on Biomarkers, Signal Pathways and Targeted Therapy	49
The Impact of Histopathological Features on the Prognosis of Oral Squamous Cell Carcinoma: A Comprehensive Review and Meta-Analysis	49
PPAR-γ Modulators as Current and Potential Cancer Treatments	49
SGK1 in Human Cancer: Emerging Roles and Mechanisms	49
Rac1, A Potential Target for Tumor Therapy	49
Anlotinib: A Novel Targeted Drug for Bone and Soft Tissue Sarcoma	49
Breast Cancer Stem-Like Cells in Drug Resistance: A Review of Mechanisms and Novel Therapeutic Strategies to Overcome Drug Resistance	49
Macrophages in Osteosarcoma Immune Microenvironment: Implications for Immunotherapy	49
Preoperative Systemic Immune–Inflammation Index (SII) as a Superior Predictor of Long-Term Survival Outcome in Patients With Stage I–II Gastric Cancer After Radical Surgery	49
An Integrative Pan-Cancer Analysis Revealing LCN2 as an Oncogenic Immune Protein in Tumor Microenvironment	49
Cancer-Associated Fibroblast Density, Prognostic Characteristics, and Recurrence in Head and Neck Squamous Cell Carcinoma: A Meta-Analysis	49
The Functions, Methods, and Mobility of Mitochondrial Transfer Between Cells	48
Artificial intelligence assists precision medicine in cancer treatment	48
Efficacy and Safety of Anti-PD-1 Plus Anlotinib in Patients With Advanced Non–Small-Cell Lung Cancer After Previous Systemic Treatment Failure—A Retrospective Study	48
High ATP Production Fuels Cancer Drug Resistance and Metastasis: Implications for Mitochondrial ATP Depletion Therapy	48
The Relationship of Redox With Hallmarks of Cancer: The Importance of Homeostasis and Context	47
The Role of Gut Microbiota in Lung Cancer: From Carcinogenesis to Immunotherapy	47
Epidrug Repurposing: Discovering New Faces of Old Acquaintances in Cancer Therapy	47
Targeting KRAS: The Elephant in the Room of Epithelial Cancers	47
m6A Modification: A Double-Edged Sword in Tumor Development	47
The Applications of Gold Nanoparticles in the Diagnosis and Treatment of Gastrointestinal Cancer	47
Single-Cell RNA-Seq Analysis Reveals Microenvironmental Infiltration of Plasma Cells and Hepatocytic Prognostic Markers in HCC With Cirrhosis	47
Complement C1q (C1qA, C1qB, and C1qC) May Be a Potential Prognostic Factor and an Index of Tumor Microenvironment Remodeling in Osteosarcoma	47
Introducing the New Surgical Robot HUGO™ RAS: System Description and Docking Settings for Gynecological Surgery	47
First-in-Human Trial of EphA2-Redirected CAR T-Cells in Patients With Recurrent Glioblastoma: A Preliminary Report of Three Cases at the Starting Dose	47
Circular RNA circLMO1 Suppresses Cervical Cancer Growth and Metastasis by Triggering miR-4291/ACSL4-Mediated Ferroptosis	46
TCR-T Immunotherapy: The Challenges and Solutions	46
Non-coding RNA in cancer drug resistance: Underlying mechanisms and clinical applications	46
Cancer Stemness: p53 at the Wheel	46
Doxorubicin-Induced Cognitive Impairment: The Mechanistic Insights	46
Metabolic Syndrome and Breast Cancer: Prevalence, Treatment Response, and Prognosis	46
Evaluating large language models on a highly-specialized topic, radiation oncology physics	46
Molecular Mechanism of β-Sitosterol and its Derivatives in Tumor Progression	46
Ocular Toxicity of Belantamab Mafodotin, an Oncological Perspective of Management in Relapsed and Refractory Multiple Myeloma	46
Long Non-Coding RNA in Gastric Cancer: Mechanisms and Clinical Implications for Drug Resistance	46
Glycosylated Nanoparticles for Cancer-Targeted Drug Delivery	46
Recent Advances in Experimental Dendritic Cell Vaccines for Cancer	46
Progress and Prospect of Immunotherapy for Triple-Negative Breast Cancer	46
Bax/Bcl-2 Cascade Is Regulated by the EGFR Pathway: Therapeutic Targeting of Non-Small Cell Lung Cancer	46
Targeted Therapeutic Strategies for Triple-Negative Breast Cancer	46
Review of Deep Learning Based Automatic Segmentation for Lung Cancer Radiotherapy	46
Technical Challenges of Real-Time Adaptive MR-Guided Radiotherapy	45
The Identification and Validation of Two Heterogenous Subtypes and a Risk Signature Based on Ferroptosis in Hepatocellular Carcinoma	45
Treatment of Retinoblastoma: What Is the Latest and What Is the Future	45
Multi-Parametric MRI-Based Radiomics Models for Predicting Molecular Subtype and Androgen Receptor Expression in Breast Cancer	45
Mechanisms and Future of Non-Small Cell Lung Cancer Metastasis	45
PSMA Expression in Glioblastoma as a Basis for Theranostic Approaches: A Retrospective, Correlational Panel Study Including Immunohistochemistry, Clinical Parameters and PET Imaging	45
The Role of Microglia in Glioblastoma	45
MR-Guided Radiotherapy for Liver Malignancies	45
Relationship between copper and immunity: The potential role of copper in tumor immunity	45
Homeobox Genes in Cancers: From Carcinogenesis to Recent Therapeutic Intervention	45
The Impact of Epstein-Barr Virus Infection on Epigenetic Regulation of Host Cell Gene Expression in Epithelial and Lymphocytic Malignancies	45
Calmodulin 2 Facilitates Angiogenesis and Metastasis of Gastric Cancer via STAT3/HIF-1A/VEGF-A Mediated Macrophage Polarization	45
Case Report: Prolonged Survival Following EGFRvIII CAR T Cell Treatment for Recurrent Glioblastoma	45
Surgery After Conversion Therapy With PD-1 Inhibitors Plus Tyrosine Kinase Inhibitors Are Effective and Safe for Advanced Hepatocellular Carcinoma: A Pilot Study of Ten Patients	44
Artificial Intelligence in Medical Imaging of the Breast	44
Cutaneous Melanoma Classification: The Importance of High-Throughput Genomic Technologies	44
Stigmasterol Simultaneously Induces Apoptosis and Protective Autophagy by Inhibiting Akt/mTOR Pathway in Gastric Cancer Cells	44
Emerging Autophagy Functions Shape the Tumor Microenvironment and Play a Role in Cancer Progression - Implications for Cancer Therapy	44
Volatile Organic Compounds in Human Exhaled Breath to Diagnose Gastrointestinal Cancer: A Meta-Analysis	44
Heat Shock Proteins and HSF1 in Cancer	44
The Role of Decorin and Biglycan Signaling in Tumorigenesis	44
Advancements in 3D Cell Culture Systems for Personalizing Anti-Cancer Therapies	44
Autophagy Regulation and Photodynamic Therapy: Insights to Improve Outcomes of Cancer Treatment	44
The Tumor Microenvironment Factors That Promote Resistance to Immune Checkpoint Blockade Therapy	44
Brain Shift in Neuronavigation of Brain Tumors: An Updated Review of Intra-Operative Ultrasound Applications	43
FAPI-PET/CT in Cancer Imaging: A Potential Novel Molecule of the Century	43
Identification of an m6A-Related lncRNA Signature for Predicting the Prognosis in Patients With Kidney Renal Clear Cell Carcinoma	43
The Diagnostic Role of 18F-Choline, 18F-Fluciclovine and 18F-PSMA PET/CT in the Detection of Prostate Cancer With Biochemical Recurrence: A Meta-Analysis	43
New Perspectives for Resistance to PARP Inhibitors in Triple-Negative Breast Cancer	43
Carfilzomib: A Promising Proteasome Inhibitor for the Treatment of Relapsed and Refractory Multiple Myeloma	43
Tyrosine Kinase ROR1 as a Target for Anti-Cancer Therapies	43
The tRNA-Derived Fragment-3017A Promotes Metastasis by Inhibiting NELL2 in Human Gastric Cancer	43
IDH1/IDH2 Inhibition in Acute Myeloid Leukemia	43
Allicin and Digestive System Cancers: From Chemical Structure to Its Therapeutic Opportunities	43
Autophagy and Cancer Dormancy	43
HER2 Positivity in Histological Subtypes of Salivary Gland Carcinoma: A Systematic Review and Meta-Analysis	43
Targeting Sphingolipids for Cancer Therapy	43
Review of Atypical and Anaplastic Meningiomas: Classification, Molecular Biology, and Management	43
Vascular Normalization: A New Window Opened for Cancer Therapies	43
Long Noncoding RNA MIR210HG Promotes the Warburg Effect and Tumor Growth by Enhancing HIF-1α Translation in Triple-Negative Breast Cancer	43